FDA Inspection 1057873 — Apotex Pharmachem India Pvt Ltd.

Apotex Pharmachem India Pvt Ltd. — FEI 3005466325

The FDA completed an inspection of Apotex Pharmachem India Pvt Ltd. on June 26, 2018 in Bangalore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 26, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bangalore (India)